← Leaderboards
James G. Herman
Johns Hopkins University
$8,069,882
Attributed
$9,630,363
Total exposure
14
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,169,695 · 16
By mechanism
U2C$6,462,112 · 7
P50$6,014,317 · 3
U01$3,120,963 · 1
R33$1,074,281 · 1
P30$268,422 · 3
R21$229,600 · 1
Top collaborators
- Tza-Huei Jeff Wang10 shared
- Robert H. Christenson2 shared
- Sanford A Stass2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Tza-Huei Jeff Wang$29,391,444
- John T. Isaacs$6,502,533
- Jennifer Marie Coughlin$8,255,422
- Katrin I Andreasson$26,152,030
- Janet T. Holbrook$51,624,279
Others in their field
Top investigators on “Malignant Neoplasm Of Lung”
- David Heimbrook · Leidos Biomedical Research, Inc.$349,639,893
- Richard K. Wilson · Washington University$202,666,376
- Walter John Curran · Thomas Jefferson University$94,674,902
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$61,410,512
- Norman Wolmark · Nsabp Foundation, Inc.$54,610,124
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
Research focus
Malignant Neoplasm Of LungMalignant NeoplasmsLungFundingSamplingDna MethylationBiological MarkersDetectionCessation Of LifeMethylationScreeningEarly DiagnosisResearch PersonnelProspectiveUnited StatesMortalityTumorCancer EtiologyScreening For CancerBiologicalPerformancePlasmaEarly Detection Research NetworkBiomarker Development
Grant awards (44)
Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies$807,262
U2C · FY2025 · CA · contact PI
Core - Biomarker Development Laboratory (BDL)$368,645
U2C · FY2025 · CA · contact PI
Administrative Core$280,680
U2C · FY2025 · CA · contact PI
Core - Biomarker Reference Laboratory (BRL)$157,937
U2C · FY2025 · CA · contact PI
Cancer Epidemiology and Prevention Program$38,529
P30 · FY2025 · CA · contact PI
Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies$846,821
U2C · FY2024 · CA · contact PI
Core - Biomarker Development Laboratory (BDL)$377,760
U2C · FY2024 · CA · contact PI
Administrative Core$346,945
U2C · FY2024 · CA · contact PI
Core - Biomarker Reference Laboratory (BRL)$122,116
U2C · FY2024 · CA · contact PI
Cancer Epidemiology and Prevention Program$40,109
P30 · FY2024 · CA · contact PI
Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies$879,659
U2C · FY2023 · CA · contact PI
Core - Biomarker Development Laboratory (BDL)$459,827
U2C · FY2023 · CA · contact PI
Administrative Core$299,550
U2C · FY2023 · CA · contact PI
Core - Biomarker Reference Laboratory (BRL)$197,728
U2C · FY2023 · CA · contact PI
Cancer Epidemiology and Prevention Program$40,109
P30 · FY2023 · CA · contact PI
Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies$658,591
U2C · FY2022 · CA · contact PI
Core - Biomarker Development Laboratory (BDL)$356,762
U2C · FY2022 · CA · contact PI
Core - Biomarker Reference Laboratory (BRL)$210,741
U2C · FY2022 · CA · contact PI
Administrative Core$91,088
U2C · FY2022 · CA · contact PI
Cancer Epidemiology and Prevention Program$40,109
P30 · FY2022 · CA · contact PI
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung CancerÂ$233,698
U01 · FY2021 · CA · contact PI
Cancer Epidemiology and Prevention Program$35,587
P30 · FY2021 · CA · contact PI
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung CancerÂ$572,321
U01 · FY2020 · CA · contact PI
Cancer Epidemiology and Prevention Program$39,479
P30 · FY2020 · CA · contact PI
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung CancerÂ$558,907
U01 · FY2019 · CA · contact PI
Lung Cancer Program (Project-009)$34,500
P30 · FY2019 · CA · contact PI
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung CancerÂ$579,985
U01 · FY2018 · CA · contact PI
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung CancerÂ$581,405
U01 · FY2017 · CA · contact PI
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung CancerÂ$594,647
U01 · FY2016 · CA · contact PI
SPORE in Lung Cancer$2,185,000
P50 · FY2015 · CA · contact PI
SPORE in Lung Cancer$2,161,999
P50 · FY2014 · CA · contact PI
P1: Epigenetic Staging and Therapy for Lung Cancers$319,995
P50 · FY2013 · CA · contact PI
P1: Epigenetic Staging and Therapy for Lung Cancers$341,984
P50 · FY2012 · CA · contact PI
P1: Epigenetic Staging and Therapy for Lung Cancers$298,866
P50 · FY2011 · CA · contact PI
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer$262,481
R33 · FY2011 · CA · contact PI
P1: Epigenetic Staging and Therapy for Lung Cancers$279,934
P50 · FY2010 · CA · contact PI
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer$270,600
R33 · FY2010 · CA · contact PI
P1: Epigenetic Staging and Therapy for Lung Cancers$426,539
P50 · FY2009 · CA · contact PI
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer$270,600
R33 · FY2009 · CA · contact PI
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer$270,600
R33 · FY2008 · CA · contact PI
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer$229,600
R21 · FY2007 · CA · contact PI
MOLECULAR DETECTION OF BREAST CANCER$0
P50 · FY2002 · CA
MOLECULAR DETECTION OF BREAST CANCER$0
P50 · FY2001 · CA
MOLECULAR DETECTION OF BREAST CANCER$0
P50 · FY2000 · CA